Please login to the form below
New senior hires and promotions at S&H
Sudler & Hennessey has announced new appointments and promotions to various senior roles across the company
Global healthcare marketing and communications company, Sudler & Hennessey (S&H), has announced the appointments of Aimee Roca as senior vice president management supervisor and Tim O'Grady as vice president account supervisor.
Additionally, the company has promoted Jessica Riebe to senior vice president at S&H's medical education division, IntraMed and Jennifer Rodriguez, to vice president, director facilities management for both the New York and New Jersey offices.
Roca has a strong understanding of the oncology market; her oncology brand experience includes Arimidex, Faslodex and Femara. She previously worked at Agency Rx.
O'Grady joins S&H from Concentric Pharma. His most recent brand experience includes Betaseron and Humira. He has over 13 years pharmaceutical marketing experience having worked on both the promotional and medical education side of the business.
Share
Related Hub content
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
